연세대학교 생물학과 학사 (1997) 연세대학교 의학과 학사 (2007) 연세대학교 생물학과 석사 (1999) 연세대학교 의학과 박사 (2017)
경력
2012~2014 연세대학교 의과대학 정형외과학교실 임상강사 2016~2018 연세대학교 의과대학 정형외과학교실 임상조교수 2019~현재 연세대학교 의과대학 정형외과학교실 조교수
논문
Sequence-specific binding to telomeric DNA by CEH-37, a homeodomain protein in the nematode Caenorhabditis elegans JOURNAL OF BIOLOGICAL CHEMISTRY 278/30 :28038-28044,2003
요추부 척추관 협착증을 가진 50세 이상 여자 환자의 골다공증 또는 슬관절 퇴행성 관절염의 유병율 대한골대사학회지 18/1 :33-38,2011
Arthroscopic Partial Repair of Irreparable Large to Massive Rotator Cuff Tears ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY 28/6 :761-768,2012
연부 조직 육종에 대한 무계획적 절제술: 환자의 임상적 특징 및 치료 결과 대한골관절종양학회지 18/2 :72-77,2012
Prognostic Factor Analysis in Patients with Metastatic Spine Disease Depending on Surgery and Conservative Treatment: Review of 577 Cases ANNALS OF SURGICAL ONCOLOGY 20/1 :40-46,2013
천골 및 골반골에 발생한 거대세포종에 대한 동맥 색전술 치료의 효용성 분석(Analysis for Usefulness of Arterial Embolization on Sacral and Pelvic Giant Cell Tumors) 대한골관절종양학회지 19/2 :50-55,2013
Postoperative nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma BMC CANCER 14/666 :1-10,2014
Secondary Malignant Neoplasms after Osteosarcoma: Early Onset and Cumulative Alkylating Agent Dose Dependency ANNALS OF SURGICAL ONCOLOGY 22/3 :859-865,2015
A new relative tumor sizing method in epi-metaphyseal osteosarcoma BMC CANCER 15/284 :1-8,2015
Time to Surgery and Injury Severity Score Journal of Trauma and Injury 29/4 :151-154,2016
Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma CANCER MEDICINE 6/6 :1,311-1,322,2017
Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcoma JOURNAL OF SURGICAL ONCOLOGY 115/6 :752-759,2017
Optimal radiotherapy strategy for primary or recurrent fibromatosis and long-term results PLOS ONE 13/5 :1-13,2018
Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images JOURNAL OF ORTHOPAEDIC SCIENCE 23/3 :570-577,2018
Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma. ONCOLOGY 96/2 :59-69,2019